share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

SEC ·  Sep 6 05:29

Summary by Futu AI

On September 3, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock at a price of $6.2652 per share. The transaction, conducted on the open market, resulted in a total value of approximately $71,717.74. Following the sale, Borgeson directly holds a total of 7,121,322 shares in the company. This sale reflects a transaction in Recursion Pharmaceuticals' stock and may be of interest to current or potential investors.
On September 3, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock at a price of $6.2652 per share. The transaction, conducted on the open market, resulted in a total value of approximately $71,717.74. Following the sale, Borgeson directly holds a total of 7,121,322 shares in the company. This sale reflects a transaction in Recursion Pharmaceuticals' stock and may be of interest to current or potential investors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated